Association between the triglyceride glucose index and heart failure: NHANES 2007–2018

BackgroundPatients with heart failure (HF) were compared with non-HF people to explore the relationship between the triglyceride glucose (TyG) index and HF in participants with cardiovascular and cerebrovascular diseases.MethodsTyG index was calculated as ln [fasting triglyceride (mg/dL) × fasting g...

Full description

Bibliographic Details
Main Authors: Fudan Zhang, Xu Hou
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1322445/full
_version_ 1797349412075208704
author Fudan Zhang
Xu Hou
author_facet Fudan Zhang
Xu Hou
author_sort Fudan Zhang
collection DOAJ
description BackgroundPatients with heart failure (HF) were compared with non-HF people to explore the relationship between the triglyceride glucose (TyG) index and HF in participants with cardiovascular and cerebrovascular diseases.MethodsTyG index was calculated as ln [fasting triglyceride (mg/dL) × fasting glucose (mg/dL)/2]. Multivariate logistic regression models were used to investigate the association between the TyG index and the risk of HF. Restricted cubic spline (RCS) analysis was applied to evaluate the dose–response relationship between the TyG index and the risk of HF.ResultsNational Health and Nutrition Examination Survey (NHANES) (2007–2018) was used to analyze the association between TyG and HF in patients. A total of 13,825 participants who had their TyG index measured were included, involving 435 individuals with HF and 13,390 individuals without HF. Those with HF had higher levels of the TyG index compared with those without HF (8.91 ± 0.74 vs. 8.57 ± 0.66, p < 0.001). The odds ratio (OR) of HF for the TyG index from logistic regression was 1.644 and 1.057 in Model 1 (without adjusting for any variables) and Model 4 (adjusted for all covariates), respectively. Compared with individuals with Q1, a higher TyG index was related to the increased risk of HF. Model 1 showed that there was a linear dose–response relationship between the TyG index and HF (p = 0.686). The TyG index predicted the area of the receiver operating characteristic (ROC) curve of 0.602 (95% CI: 0.575–0.629, p < 0.001) and the optimal cutoff value was 8.91.ConclusionThe TyG index was positively associated with the risk of HF. The TyG index may be a therapeutic target and an important predictor of HF.
first_indexed 2024-03-08T12:29:53Z
format Article
id doaj.art-1693ff84fa504fac952b21ff9ca3bcf6
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-03-08T12:29:53Z
publishDate 2024-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-1693ff84fa504fac952b21ff9ca3bcf62024-01-22T04:40:09ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922024-01-011410.3389/fendo.2023.13224451322445Association between the triglyceride glucose index and heart failure: NHANES 2007–2018Fudan Zhang0Xu Hou1Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, ChinaDepartment of Endocrinology and Metabolic Diseases, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, ChinaBackgroundPatients with heart failure (HF) were compared with non-HF people to explore the relationship between the triglyceride glucose (TyG) index and HF in participants with cardiovascular and cerebrovascular diseases.MethodsTyG index was calculated as ln [fasting triglyceride (mg/dL) × fasting glucose (mg/dL)/2]. Multivariate logistic regression models were used to investigate the association between the TyG index and the risk of HF. Restricted cubic spline (RCS) analysis was applied to evaluate the dose–response relationship between the TyG index and the risk of HF.ResultsNational Health and Nutrition Examination Survey (NHANES) (2007–2018) was used to analyze the association between TyG and HF in patients. A total of 13,825 participants who had their TyG index measured were included, involving 435 individuals with HF and 13,390 individuals without HF. Those with HF had higher levels of the TyG index compared with those without HF (8.91 ± 0.74 vs. 8.57 ± 0.66, p < 0.001). The odds ratio (OR) of HF for the TyG index from logistic regression was 1.644 and 1.057 in Model 1 (without adjusting for any variables) and Model 4 (adjusted for all covariates), respectively. Compared with individuals with Q1, a higher TyG index was related to the increased risk of HF. Model 1 showed that there was a linear dose–response relationship between the TyG index and HF (p = 0.686). The TyG index predicted the area of the receiver operating characteristic (ROC) curve of 0.602 (95% CI: 0.575–0.629, p < 0.001) and the optimal cutoff value was 8.91.ConclusionThe TyG index was positively associated with the risk of HF. The TyG index may be a therapeutic target and an important predictor of HF.https://www.frontiersin.org/articles/10.3389/fendo.2023.1322445/fulltriglyceride glucose indexheart failureNHANESnonlinear associationscardiovascular disease
spellingShingle Fudan Zhang
Xu Hou
Association between the triglyceride glucose index and heart failure: NHANES 2007–2018
Frontiers in Endocrinology
triglyceride glucose index
heart failure
NHANES
nonlinear associations
cardiovascular disease
title Association between the triglyceride glucose index and heart failure: NHANES 2007–2018
title_full Association between the triglyceride glucose index and heart failure: NHANES 2007–2018
title_fullStr Association between the triglyceride glucose index and heart failure: NHANES 2007–2018
title_full_unstemmed Association between the triglyceride glucose index and heart failure: NHANES 2007–2018
title_short Association between the triglyceride glucose index and heart failure: NHANES 2007–2018
title_sort association between the triglyceride glucose index and heart failure nhanes 2007 2018
topic triglyceride glucose index
heart failure
NHANES
nonlinear associations
cardiovascular disease
url https://www.frontiersin.org/articles/10.3389/fendo.2023.1322445/full
work_keys_str_mv AT fudanzhang associationbetweenthetriglycerideglucoseindexandheartfailurenhanes20072018
AT xuhou associationbetweenthetriglycerideglucoseindexandheartfailurenhanes20072018